1.
Antimicrob Steward Healthc Epidemiol
; 3(1): e92, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37228506
RESUMO
A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated ß-lactams during follow-up. Providers found the PATS valuable.